| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.035 | 0.9 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |